| Report ID | 283125 |
| Drug Identification Number | 02506564 |
| Brand name | TRURAPI |
| Common or Proper name | insulin aspart injection |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN ASPART |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | CARTRIDGE |
| Anatomical Therapeutical Chemical (ATC) code | A10AB |
| Anatomical Therapeutical Chemical (ATC) description | INSULINS AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2026-04-16 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-16 |
| Company comments | Supply Delay The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-16 | French | Compare |
| v1 | 2026-04-16 | English | Compare |
Showing 1 to 2 of 2